This is a rare genetic condition that affects the immune system. It causes problems with the production of certain types of blood cells, leading to infections and sometimes blood cancers. It can also affect the lungs and the lymphatic system.
Every report comes from a Lived member, sent anonymously.
Have you had Stem Cell Transplant for GATA2 Deficiency?
GATA2 deficiency is a rare inherited condition that affects the bone marrow and the immune system. GATA2 is a gene that helps blood-forming stem cells develop into several kinds of white blood cells. When one copy of the gene does not work properly, the body makes too few monocytes, B cells, natural killer (NK) cells and dendritic cells, which are cells that recognize and fight viruses, mycobacteria and fungi. The result is a pattern of problems that can look unrelated at first: unusual or hard-to-clear infections, persistent warts caused by human papillomavirus (HPV), lung disease, swelling of the legs from lymphedema, and in some people hearing loss present from birth. The most serious concern is the bone marrow. Most people with GATA2 deficiency eventually develop myelodysplastic syndrome (MDS), a disorder in which the marrow makes too few healthy blood cells, and MDS can progress to acute myeloid leukemia (AML). Before the single genetic cause was found in 2011, these presentations were described as separate disorders, which is why the condition has several names, including MonoMAC syndrome and Emberger syndrome.
GATA2 deficiency is caused by a harmful change (variant) in one of a person's two copies of the GATA2 gene. It can be passed down from a parent, and a child of an affected parent has a 50% chance of inheriting the variant. It can also arise as a new change in a person with no family history. Having the variant does not predict exactly what will happen. Relatives who share the same variant can have very different experiences: one may develop leukemia as a teenager while another has no symptoms for decades. Problems usually first appear in the teens or twenties, and the risk of MDS rises with age. Researchers believe additional changes acquired in bone marrow cells over time, such as the loss of part or all of chromosome 7, help push the marrow toward MDS or leukemia.
The diagnosis is confirmed with a genetic test that finds a disease-causing variant in the GATA2 gene. What usually prompts testing is a recognizable pattern: very low monocytes on a blood count, often with low neutrophils, along with unusual infections such as nontuberculous mycobacteria (relatives of the tuberculosis germ found in soil and water), widespread warts or severe herpes infections. MDS in a child or young adult, lung changes called pulmonary alveolar proteinosis, or leg lymphedema together with hearing loss also raise the question. Once the diagnosis is made, a bone marrow biopsy shows how well the marrow is working and whether MDS or chromosome changes are present. Breathing tests and chest imaging check for lung involvement. Because the condition is inherited, parents, brothers, sisters and children are usually offered genetic counseling and testing. This can find relatives who carry the variant before they have symptoms, and it matters for transplant planning, since a relative who carries the variant should not be a stem cell donor.
The only treatment that can cure the blood and immune problems of GATA2 deficiency is an allogeneic stem cell transplant (sometimes called a bone marrow transplant), which replaces the person's blood-forming cells with healthy cells from a donor. Transplant is usually considered for people who develop MDS or leukemia, severe or repeated infections, aggressive HPV-related disease, worsening lung function or a need for regular transfusions. Specialists generally aim to transplant after the condition causes problems but before lasting organ damage. Results have improved; one recent group of patients had about 85% survival after transplant. It is still a major treatment with serious risks, including infections and graft-versus-host disease, in which donor immune cells attack the body, and timing is decided case by case. Because of this, a donor search is often started soon after diagnosis. Until transplant, or when it is not yet needed, care focuses on preventing and treating infections. Many specialists recommend azithromycin, an antibiotic, taken regularly to help prevent mycobacterial infections. HPV vaccination is encouraged early, and warts and precancerous HPV changes are watched and treated. A small number of people with low antibody levels receive immunoglobulin replacement. Some experts also advise caution with corticosteroids and other immune-suppressing medicines unless they are clearly needed.
The course of GATA2 deficiency is hard to predict. Some people have years without major problems, while others face repeated infections, lung trouble or a change in their bone marrow in adolescence. Because the condition can change, most people are followed by a team that may include a hematologist (blood specialist), an immunologist, a lung specialist and, for HPV-related care, a gynecologist or dermatologist. Regular blood counts, periodic bone marrow exams and breathing tests help catch changes early enough to plan treatment rather than react to a crisis. A successful transplant can restore normal blood and immune cells, clear stubborn infections and improve lung disease. It does not fix effects outside the blood system, such as lymphedema or hearing loss, and HPV can persist, so follow-up continues for life. Because many details of this rare condition are still being studied, families often find it helpful to be cared for at a center that has experience with it.
Ask about evaluation for GATA2 deficiency if you or your child has persistently low monocytes, unusual infections such as nontuberculous mycobacteria, warts that are widespread or keep returning, MDS at a young age, or a family history of these problems. A relative's GATA2 diagnosis is also a reason to ask about testing and counseling. If you already have the diagnosis, contact your care team promptly for a fever, new or worsening cough or shortness of breath, or new unexplained bruising, bleeding or tiredness, since these can signal an infection or a change in blood counts.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with GATA2 Deficiency is like, what's helped you, or ask the community a question.